CVE:VIV Avivagen (VIV) Stock Price, News & Analysis → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free VIV Stock Alerts C$0.0050 0.00 (0.00%) (As of 03/5/2024) Add Compare Share Share Today's RangeC$0.01▼C$0.0150-Day RangeC$0.01▼C$0.0152-Week RangeC$0.01▼C$0.08Volume2,820 shsAverage Volume49,827 shsMarket CapitalizationC$388,450.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines Get Avivagen alerts: Email Address Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About Avivagen Stock (CVE:VIV)Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.Read More VIV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VIV Stock News HeadlinesMarch 6, 2024 | investing.comAvivagen Inc (VIV)March 6, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - VIVMay 11, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...February 20, 2024 | theglobeandmail.comAvivagen: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (VIV)January 3, 2024 | finance.yahoo.comPure Harvest Corporate Group, Inc. (PHCG)November 5, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Monday (VIV)October 17, 2023 | finance.yahoo.comAvivagen Announces New 500Kg Order for OxC-beta™August 25, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Friday (VIV)May 11, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...July 31, 2023 | technews.tmcnet.comAvivagen Provides Corporate UpdatesJuly 29, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc up on Friday (VIV)July 24, 2023 | finance.yahoo.comAvivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock ProductJuly 19, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Tuesday (VIV)July 15, 2023 | theglobeandmail.comAvivagen: Top 10 Undervalued Growth Stocks on TSX-V (VIV)June 27, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc down on Monday (VIV)May 25, 2023 | msn.comAn existing Avivagen customer increases order sizeMay 25, 2023 | finance.yahoo.comAvivagen Announces Significant Increase in Sales to an Existing CustomerMay 23, 2023 | sg.finance.yahoo.comAvivagen Inc. (VIV.V)May 18, 2023 | tmcnet.comAvivagen Announces Review of Strategic AlternativesApril 27, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc down on Thursday (VIV)April 19, 2023 | finance.yahoo.comAvivagen Announces AGM ResultsApril 7, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Thursday (VIV)April 6, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Wednesday (VIV)March 28, 2023 | finance.yahoo.comAvivagen Inc. Provides Update on Securities for Service Agreements With CEO and CSOMarch 18, 2023 | finance.yahoo.comAvivagen First Quarter 2023 Earnings: CA$0.015 loss per share (vs CA$0.027 loss in 1Q 2022)February 21, 2023 | msn.comAvivagen reports FY resultsFebruary 21, 2023 | finance.yahoo.comAvivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate GrowthSee More Headlines Receive VIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/11/2024Next Earnings (Estimated)6/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:VIV CUSIPN/A CIKN/A Webwww.avivagen.com Phone613-949-8164FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-4,640,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-193.44% Debt Debt-to-Equity Ratio2,402.32 Current Ratio0.03 Quick Ratio0.30 Sales & Book Value Annual SalesC$403,780.00 Price / Sales0.96 Cash FlowC$0.00 per share Price / Cash Flow12.14 Book ValueC($0.10) per share Price / Book-0.05Miscellaneous Outstanding Shares77,690,000Free FloatN/AMarket CapC$388,450.00 OptionableNot Optionable Beta1.21 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. G. F. Kym Anthony (Age 68)CEO & Vice Chairman Comp: $361.06kDr. Graham Burton Ph.D.Co-Founder, Chief Scientific Officer & DirectorMr. Ira LevyInterim Chief Financial OfficerDr. James Nickerson Ph.D.President and Executive VP of Business Development & Product InnovationMr. Drew BasekDirector of Investor RelationsMs. Tracy Gillett BVSCDirector of Companion Animal & Marketing ManagerMore ExecutivesKey CompetitorsSugarBud Craft GrowersCVE:SUGRNeutriSci InternationalCVE:NUBioasis TechnologiesCVE:BTIImaging DynamicsCVE:IDLKiaroCVE:KOView All Competitors VIV Stock Analysis - Frequently Asked Questions How have VIV shares performed in 2024? Avivagen's stock was trading at C$0.01 at the beginning of 2024. Since then, VIV shares have increased by 0.0% and is now trading at C$0.01. View the best growth stocks for 2024 here. When is Avivagen's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024. View our VIV earnings forecast. What other stocks do shareholders of Avivagen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avivagen investors own include Astrotech (ASTC), Arcturus Therapeutics (ARCT), Aptose Biosciences (APTO), Appili Therapeutics (APLIF), Argan (AGX), Applied Genetic Technologies (AGTC), AES (AES) and AbbVie (ABBV). How do I buy shares of Avivagen? Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:VIV) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCollapse of the Petrodollar Colonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avivagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.